Financhill
Back

Intellia Therapeutics Quote, Financials, Valuation and Earnings

Intellia Therapeutics Price Quote

$27.18
-0.54 (-1.95%)
(Updated: February 20, 2024 at 5:55 PM ET)

Intellia Therapeutics Key Stats

Sell
31
Intellia Therapeutics (NTLA) is a Sell

Day range:
$27.04 - $28.11
52-week range:
$22.67 - $47.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
47.08
P/B ratio:
2.39%

Volume:
1.5M
Avg. volume:
1.5M
1-year change:
-30.4%
Market cap:
$2.5B
Revenue:
$52.1M
EPS:
$-5.35

How Much Does Intellia Therapeutics Make?

Is Intellia Therapeutics Growing As A Company?

  • What Is Intellia Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.1%
  • What Is Intellia Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Intellia Therapeutics Stock Price Performance

What Is Intellia Therapeutics 52-Week High & Low?

Intellia Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Intellia Therapeutics?

Is Intellia Therapeutics Cash Flow Positive?

  • What Is NTLA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$390.9M
  • What Is Intellia Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $529.6M
  • What Is Intellia Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$107.4M

Intellia Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    NTLA return on invested capital is -42.87%
  • What Is Intellia Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -35.09%
  • What Is NTLA Return On Equity?
    ROE is a measure of profitability and is -42.87%

Intellia Therapeutics Earnings Date & Stock Price

Intellia Therapeutics Competitors

Intellia Therapeutics Dividend Yield

Data Unavailable

Intellia Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 8.18%
Revenue: -9.6% 0.33%

Analyst Recommendations

Buy Recommendations: 17
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 77.67
Upside from Last Price: 180.18%

Major Shareholders

  • How many NTLA shares are owned by institutional investors?
    118M NTLA shares are owned by institutional investors
  • How many NTLA shares are owned by insiders?
    2.5M NTLA shares are owned by insiders